PH12013502425A1 - Smoothened polypeptides and methods of use - Google Patents
Smoothened polypeptides and methods of useInfo
- Publication number
- PH12013502425A1 PH12013502425A1 PH12013502425A PH12013502425A PH12013502425A1 PH 12013502425 A1 PH12013502425 A1 PH 12013502425A1 PH 12013502425 A PH12013502425 A PH 12013502425A PH 12013502425 A PH12013502425 A PH 12013502425A PH 12013502425 A1 PH12013502425 A1 PH 12013502425A1
- Authority
- PH
- Philippines
- Prior art keywords
- functional fragment
- inhibiting
- functional
- treating
- methods
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 239000012634 fragment Substances 0.000 abstract 4
- 230000002401 inhibitory effect Effects 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 230000003834 intracellular effect Effects 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 230000008410 smoothened signaling pathway Effects 0.000 abstract 2
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000035269 cancer or benign tumor Diseases 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- -1 host cells Substances 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000000816 peptidomimetic Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85542206P | 2006-10-31 | 2006-10-31 | |
| PCT/US2007/083027 WO2008070357A2 (en) | 2006-10-31 | 2007-10-30 | Smoothened polypeptides and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PH12013502425B1 PH12013502425B1 (en) | 2014-10-27 |
| PH12013502425A1 true PH12013502425A1 (en) | 2014-10-27 |
Family
ID=39492945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH12013502425A PH12013502425A1 (en) | 2006-10-31 | 2013-11-22 | Smoothened polypeptides and methods of use |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8198402B2 (https=) |
| EP (2) | EP2078036A2 (https=) |
| JP (3) | JP5399255B2 (https=) |
| KR (1) | KR101563010B1 (https=) |
| CN (2) | CN103435694A (https=) |
| AU (1) | AU2007329678A1 (https=) |
| CA (1) | CA2667821A1 (https=) |
| MY (2) | MY149170A (https=) |
| NZ (1) | NZ576467A (https=) |
| PH (1) | PH12013502425A1 (https=) |
| SG (2) | SG175691A1 (https=) |
| WO (1) | WO2008070357A2 (https=) |
| ZA (1) | ZA200902894B (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103435694A (zh) * | 2006-10-31 | 2013-12-11 | 美国政府卫生与公共服务部 | Smoothened多肽及使用方法 |
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| US20100297118A1 (en) * | 2007-12-27 | 2010-11-25 | Macdougall John | Therapeutic Cancer Treatments |
| WO2009086416A1 (en) * | 2007-12-27 | 2009-07-09 | Infinity Pharmaceuticals, Inc. | Therapeutic cancer treatments |
| AU2008345097A1 (en) | 2007-12-27 | 2009-07-09 | Infinity Pharmaceuticals, Inc. | Methods for stereoselective reduction |
| US8193182B2 (en) | 2008-01-04 | 2012-06-05 | Intellikine, Inc. | Substituted isoquinolin-1(2H)-ones, and methods of use thereof |
| JP6141015B2 (ja) | 2009-08-05 | 2017-06-07 | インフィニティ ファーマスーティカルズ、インク． | シクロパミン類似体の酵素によるアミノ基転移 |
| US20110183948A1 (en) * | 2010-01-15 | 2011-07-28 | Infinity Pharmaceuticals, Inc. | Treatment of fibrotic conditions using hedgehog inhibitors |
| CA2799579A1 (en) | 2010-05-21 | 2011-11-24 | Intellikine, Inc. | Chemical compounds, compositions and methods for kinase modulation |
| US9394313B2 (en) | 2010-09-14 | 2016-07-19 | Infinity Pharmaceuticals, Inc. | Transfer hydrogenation of cyclopamine analogs |
| JP2013545749A (ja) | 2010-11-10 | 2013-12-26 | インフィニティー ファーマシューティカルズ， インコーポレイテッド | 複素環化合物及びその使用 |
| TWI674262B (zh) | 2011-01-10 | 2019-10-11 | 美商英菲尼提製藥股份有限公司 | 製備異喹啉酮之方法及異喹啉酮之固體形式 |
| MX2014000648A (es) | 2011-07-19 | 2014-09-25 | Infinity Pharmaceuticals Inc | Compuestos heterociclicos y sus usos. |
| WO2013012915A1 (en) | 2011-07-19 | 2013-01-24 | Infinity Pharmaceuticals Inc. | Heterocyclic compounds and uses thereof |
| KR20140075693A (ko) | 2011-08-29 | 2014-06-19 | 인피니티 파마슈티칼스, 인코포레이티드 | 헤테로사이클릭 화합물 및 그의 용도 |
| WO2013049332A1 (en) | 2011-09-29 | 2013-04-04 | Infinity Pharmaceuticals, Inc. | Inhibitors of monoacylglycerol lipase and methods of their use |
| US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| EP2914296B2 (en) | 2012-11-01 | 2021-09-29 | Infinity Pharmaceuticals, Inc. | Treatment of cancers using pi3 kinase isoform modulators |
| CA2893133A1 (en) | 2012-11-29 | 2014-06-05 | Strasspharma Llc | Methods of modulating follicle stimulating hormone activity |
| US20160024051A1 (en) | 2013-03-15 | 2016-01-28 | Infinity Pharmaceuticals, Inc. | Salts and solid forms of isoquinolinones and composition comprising and methods of using the same |
| US9192609B2 (en) | 2013-04-17 | 2015-11-24 | Hedgepath Pharmaceuticals, Inc. | Treatment and prognostic monitoring of proliferation disorders using hedgehog pathway inhibitors |
| SG11201509842SA (en) | 2013-05-30 | 2015-12-30 | Infinity Pharmaceuticals Inc | Treatment of cancers using pi3 kinase isoform modulators |
| WO2015051241A1 (en) | 2013-10-04 | 2015-04-09 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| MX2021012208A (es) | 2013-10-04 | 2023-01-19 | Infinity Pharmaceuticals Inc | Compuestos heterocíclicos y usos de los mismos. |
| WO2015061204A1 (en) | 2013-10-21 | 2015-04-30 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| NZ724368A (en) | 2014-03-19 | 2023-07-28 | Infinity Pharmaceuticals Inc | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
| US20150320754A1 (en) | 2014-04-16 | 2015-11-12 | Infinity Pharmaceuticals, Inc. | Combination therapies |
| WO2015168079A1 (en) | 2014-04-29 | 2015-11-05 | Infinity Pharmaceuticals, Inc. | Pyrimidine or pyridine derivatives useful as pi3k inhibitors |
| WO2016054491A1 (en) | 2014-10-03 | 2016-04-07 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| KR101723649B1 (ko) | 2014-10-23 | 2017-04-06 | 서울대학교산학협력단 | 신규한 펩티드 화합물, 이의 생산 방법, 및 이의 용도 |
| CA2988289C (en) | 2015-06-04 | 2023-12-05 | PellePharm, Inc. | Topical formulations for delivery of hedgehog inhibitor compounds and use thereof |
| EP4585268A3 (en) | 2015-09-14 | 2025-10-15 | Twelve Therapeutics, Inc. | Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same |
| US20170231968A1 (en) | 2016-02-11 | 2017-08-17 | PellePharm, Inc. | Method for relief of and treatment of pruritus |
| JP6889432B2 (ja) * | 2016-04-28 | 2021-06-18 | 学校法人甲南学園 | 樹脂固定ペプチド |
| WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
| RU2754507C2 (ru) | 2016-06-24 | 2021-09-02 | Инфинити Фармасьютикалз, Инк. | Комбинированная терапия |
| WO2018150430A1 (en) * | 2017-02-19 | 2018-08-23 | The National Institute for Biotechnology in the Negev Ltd. | Peptide kinase inhibitors and methods of use thereof |
| CN108644311B (zh) * | 2018-05-22 | 2019-09-06 | 东北大学 | 一种基于硬化立方刚度吸振器实现方法及吸振器 |
| US12605387B2 (en) | 2020-07-24 | 2026-04-21 | Secura Bio, Inc. | Treatment of cancers using PI3 kinase isoform modulators |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4450150A (en) | 1973-05-17 | 1984-05-22 | Arthur D. Little, Inc. | Biodegradable, implantable drug delivery depots, and method for preparing and using the same |
| IN165717B (https=) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| JP3266311B2 (ja) | 1991-05-02 | 2002-03-18 | 生化学工業株式会社 | 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤 |
| AU8380898A (en) * | 1997-07-01 | 1999-01-25 | Ingham, Philip W | Vertebrate smoothened gene, gene products, and uses related thereto |
| IL125608A0 (en) * | 1998-07-30 | 1999-03-12 | Yeda Res & Dev | Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| US6683192B2 (en) * | 2000-03-30 | 2004-01-27 | Curis, Inc. | Small organic molecule regulators of cell proliferation |
| AU2001257169C1 (en) * | 2000-04-21 | 2011-06-16 | Tufts Medical Center, Inc. | G-protein coupled receptor (GPCR) agonists and antagonists and methods of activating and inhibiting GPCR using the same |
| ES2250434T3 (es) * | 2001-07-02 | 2006-04-16 | Tas, Sinan | Utilizacion de ciclopamina en el tratamiento del carcinoma de celulas basales y de otros tumores. |
| JP4658473B2 (ja) * | 2001-07-27 | 2011-03-23 | キュリス，インコーポレイテッド | ヘッジホッグシグナル伝達経路メディエーター、それに関連した組成物及び利用 |
| CA2529863A1 (en) * | 2003-06-17 | 2004-12-23 | Vib Vzw | Peptide combos and their uses |
| EP1814911A2 (en) | 2004-11-04 | 2007-08-08 | New England Medical Center Hospitals, Inc. | G protein coupled receptor agonists and antagonists and methods of use |
| US8088976B2 (en) * | 2005-02-24 | 2012-01-03 | Monsanto Technology Llc | Methods for genetic control of plant pest infestation and compositions thereof |
| US20070266449A1 (en) * | 2006-05-12 | 2007-11-15 | Zivin Robert A | Generation of animal models |
| CN103435694A (zh) * | 2006-10-31 | 2013-12-11 | 美国政府卫生与公共服务部 | Smoothened多肽及使用方法 |
-
2007
- 2007-10-30 CN CN2013103343899A patent/CN103435694A/zh active Pending
- 2007-10-30 CA CA002667821A patent/CA2667821A1/en not_active Abandoned
- 2007-10-30 WO PCT/US2007/083027 patent/WO2008070357A2/en not_active Ceased
- 2007-10-30 MY MYPI20091748A patent/MY149170A/en unknown
- 2007-10-30 MY MYPI2013000956A patent/MY181496A/en unknown
- 2007-10-30 EP EP07871292A patent/EP2078036A2/en not_active Withdrawn
- 2007-10-30 NZ NZ576467A patent/NZ576467A/xx not_active IP Right Cessation
- 2007-10-30 AU AU2007329678A patent/AU2007329678A1/en not_active Abandoned
- 2007-10-30 CN CN2007800460855A patent/CN101616931B/zh not_active Expired - Fee Related
- 2007-10-30 SG SG2011080447A patent/SG175691A1/en unknown
- 2007-10-30 US US12/513,091 patent/US8198402B2/en not_active Expired - Fee Related
- 2007-10-30 EP EP11179413A patent/EP2431388A1/en not_active Withdrawn
- 2007-10-30 SG SG2012007373A patent/SG178743A1/en unknown
- 2007-10-30 JP JP2009534941A patent/JP5399255B2/ja not_active Expired - Fee Related
- 2007-10-30 KR KR1020097008873A patent/KR101563010B1/ko not_active Expired - Fee Related
-
2009
- 2009-04-28 ZA ZA200902894A patent/ZA200902894B/xx unknown
-
2012
- 2012-05-14 US US13/470,965 patent/US8546524B2/en not_active Expired - Fee Related
-
2013
- 2013-07-19 JP JP2013150706A patent/JP5739484B2/ja not_active Expired - Fee Related
- 2013-08-01 US US13/956,628 patent/US20130316957A1/en not_active Abandoned
- 2013-11-22 PH PH12013502425A patent/PH12013502425A1/en unknown
-
2015
- 2015-04-23 JP JP2015088291A patent/JP2015180630A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN103435694A (zh) | 2013-12-11 |
| JP5399255B2 (ja) | 2014-01-29 |
| WO2008070357A3 (en) | 2009-02-26 |
| KR20090084839A (ko) | 2009-08-05 |
| JP2013255500A (ja) | 2013-12-26 |
| PH12013502425B1 (en) | 2014-10-27 |
| EP2078036A2 (en) | 2009-07-15 |
| US20130316957A1 (en) | 2013-11-28 |
| MY181496A (en) | 2020-12-23 |
| CA2667821A1 (en) | 2008-06-12 |
| JP2015180630A (ja) | 2015-10-15 |
| CN101616931B (zh) | 2013-08-21 |
| KR101563010B1 (ko) | 2015-10-26 |
| EP2431388A1 (en) | 2012-03-21 |
| CN101616931A (zh) | 2009-12-30 |
| WO2008070357A9 (en) | 2008-08-14 |
| ZA200902894B (en) | 2010-04-28 |
| US20100093625A1 (en) | 2010-04-15 |
| US8198402B2 (en) | 2012-06-12 |
| MY149170A (en) | 2013-07-31 |
| US8546524B2 (en) | 2013-10-01 |
| JP2010508305A (ja) | 2010-03-18 |
| AU2007329678A1 (en) | 2008-06-12 |
| WO2008070357A2 (en) | 2008-06-12 |
| SG175691A1 (en) | 2011-11-28 |
| US20120282196A1 (en) | 2012-11-08 |
| SG178743A1 (en) | 2012-03-29 |
| NZ576467A (en) | 2012-03-30 |
| HK1137031A1 (en) | 2010-07-16 |
| JP5739484B2 (ja) | 2015-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013502425B1 (en) | Smoothened polypeptides and methods of use | |
| Keiper et al. | Protein synthesis initiation factor 4G | |
| KR102694658B1 (ko) | 혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물 | |
| CY1121132T1 (el) | ΠΛΗΡΩΣ-ΑΝΘΡΩΠΙΝΑ ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ANTI-vap-1 | |
| MX2024005678A (es) | Receptores de celulas t que reconocen p53 mutado. | |
| DK1641818T3 (da) | Polypeptider der har bindingsaffinitet for HER2 | |
| IN2012DN03368A (https=) | ||
| MX2022010175A (es) | Proteinas de union a flt3 y metodos de uso. | |
| WO2004078777A3 (en) | Dipeptidyl-peptidase protected proteins | |
| WO2011036442A3 (en) | Thrombin c- terminal polypeptides and uses thereof for treating inflammation coagulation disorders | |
| NZ599792A (en) | Immunomodulatory polypeptides derived from il- 2 and their use thereof in the therapeutic of cancer and chronic infections | |
| MX2021015877A (es) | Receptores de celulas t que reconocen la mutacion r175h o y220c en p53. | |
| BR112013029409A8 (pt) | produtos farmacêuticos de peptídeo melhorados para resistência à insulina | |
| ATE482972T1 (de) | Tgf-beta1-bindende und geträgerte peptide | |
| WO2020186207A3 (en) | Non-viral dna vectors and uses thereof for expressing fviii therapeutics | |
| WO2012061683A3 (en) | Methods for treating cancer | |
| WO2006090810A3 (en) | Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides | |
| WO2011156453A3 (en) | Therapeutic peptides | |
| MX2020013296A (es) | Composiciones que contienen inhibidor de proteasa recombinante, metodos para producir las mismas y usos de las mismas. | |
| WO2008040190A8 (fr) | Petits peptides pour anti-angiogenèse et utilisation de ceux-ci | |
| MX2025007855A (es) | Proteina triespecifica dirigida a trop2 para el tratamiento del cancer | |
| WO2010117997A3 (en) | Peptide targeting of inner ear cells | |
| SE0301987D0 (sv) | New polypeptide | |
| WO2005123760A3 (en) | Treating cancer | |
| CY1111004T1 (el) | Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης |